Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Morphic Holding (MORF) is now available.
Morphic Holding, Inc. has launched an at-the-market offering program allowing for the sale of up to $350 million of its common stock through TD Securities (USA) LLC. This flexible financing strategy enables the company to sell shares at prevailing market prices, with TD Cowen receiving a commission of up to 3%. Morphic intends to use the proceeds for general corporate purposes, including research, clinical trials, and potential acquisitions. The move follows the company’s termination of a previous agreement with Jefferies LLC, under which it sold over $139 million in common stock.
See more insights into MORF stock on TipRanks’ Stock Analysis page.